GMAB Genmab A/S

NASDAQ
$50.97

Genmab A/S (GMAB) Earnings News

Earnings press releases, previews and reviews for Genmab A/S (GMAB), newest first. Our most recent is review: Genmab Tops EPS Estimates as Phase 3 Wins Overshadow Slowing Profit Growth and Flat Epkinly Sales.